Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102906 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons OpenAlex Published psilocybin DepressionObservational StudyTreatment-Resistant Depression Observational Study More
Select for export The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17159/2077-4907/2023/ldd.v27.1 Copy citation Copy BibTeX Law Democracy & Development 2022-12-31 Sebastian William Foster OpenAlex Published psilocybin Safety Other More
Select for export Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.2022816 PubMed 35000559 Copy citation Copy BibTeX Journal of psychoactive drugs 2022-12-31 Simonsson O, Goldberg SB PubMed Published psilocybin Randomized Controlled TrialObservational StudySafety Randomized Controlled Trial More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Efficacy and Safety of Psychedelics in Treating Anxiety Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31486/toj.23.0076 PubMed 38143548 Copy citation Copy BibTeX Ochsner Journal 2022-12-31 Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau OpenAlex Published psilocybin AnxietyAgingClinical Trial Clinical Trial More
Select for export Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1353/pbm.2023.0007 PubMed 38662012 Copy citation Copy BibTeX Perspectives in biology and medicine 2022-12-31 Gail A. Edelsohn, Dominic Sisti OpenAlex Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.medj.2022.12.003 PubMed 36640755 Copy citation Copy BibTeX Med 2022-12-31 Natalie Gukasyan OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Is psilocybin an effective antidepressant and what is its Mechanism of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.xcrm.2022.100906 PubMed 36652915 Copy citation Copy BibTeX Unknown journal 2022-12-31 Mann JJ. Europe PMC Published psilocybin DepressionMechanism of ActionSafety Other More
Select for export Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2054746 PubMed 35315749 Copy citation Copy BibTeX Journal of psychoactive drugs 2022-12-31 Shaw L, Rea K, Lachowsky NJ, Roth EA PubMed Published psilocybin AgingSafety Qualitative Study More
Select for export The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials. Abstract available at the source but not redistributed here. Read at source. Details PubMed 37387703 Copy citation Copy BibTeX Unknown journal 2022-12-31 IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J Europe PMC Published psilocybin DepressionAnxietyWellbeing Randomized Controlled Trial More
Select for export Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyt.2023.1191970 PubMed 37252138 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD PubMed Published psilocybin Safety Other More
Select for export Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1144276 PubMed 37435402 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Phan AN, Terry GE PubMed Published psilocybin AddictionMechanism of ActionSystematic Review Systematic Review More
Select for export Medical student attitudes and perceptions of psychedelic-assisted therapies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1190507 PubMed 37441143 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Li I, Fong R, Hagen M, Tabaac B PubMed Published psilocybin Observational StudySafety Observational Study More
Select for export Case report: Psychedelic-induced seizures captured by intracranial electrocorticography. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fneur.2023.1214969 PubMed 37456653 Copy citation Copy BibTeX Frontiers in neurology 2022-12-31 Blond BN, Schindler EAD PubMed Published psilocybin Case ReportSafety Case Report More
Select for export Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyt.2023.1305478 PubMed 37928914 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Barnett BS, Bassir Nia A, Sackett NB, Weleff J PubMed Published psilocybin AddictionMechanism of ActionSafety Other More
Select for export "How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2201263 PubMed 37078418 Copy citation Copy BibTeX Journal of psychoactive drugs 2022-12-31 Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF PubMed Published psilocybin Review ArticleObservational StudySafety Review Article More
Select for export Biological embedding of early trauma: the role of higher prefrontal synaptic strength. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/20008066.2023.2246338 PubMed 37642398 Copy citation Copy BibTeX Unknown journal 2022-12-30 Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG. Europe PMC Published psilocybin PTSDNeuroplasticityPharmacology Other More
Select for export Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109375 PubMed 36529260 Copy citation Copy BibTeX Unknown journal 2022-12-15 Heal DJ, Gosden J, Smith SL, Atterwill CK. Europe PMC Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export “A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0279073 PubMed 36516137 Copy citation Copy BibTeX PLoS ONE 2022-12-13 Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley OpenAlex Published psilocybin DepressionAddictionEmotional Processing Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
